Last reviewed · How we verify

NCT03982563

Computerized Single-Session Interventions for Indian Adolescents

Completed NA Last updated 29 June 2020
What this trial tests

NA trial testing Growth Mindset in Well-being in 958 participants. Completed in 4 June 2020.

Timeline
31 July 2019
Primary endpoint
15 March 2020
4 June 2020

Quick facts

Lead sponsorUniversity of Pennsylvania
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment958
Start date31 July 2019
Primary completion15 March 2020
Estimated completion4 June 2020
Sites4 locations across India

Drugs / interventions tested

Conditions studied

Sponsor

University of Pennsylvania

Who can join

Adults 12 to 18, any sex, with Well-being or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall aim of this project is to understand if single-session interventions are acceptable, culturally appropriate, and effective for Indian adolescents. The investigators will be examining the effects of three interventions on the well-being and mental health of adolescents. The investigators hypothesize that at least one of the three interventions will yield statistically significant improvements in wellbeing and mental health relative to a study skills control condition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Growth Mindset

Trials testing the same drug.

Other recruiting trials for Well-being

Currently open trials in the same condition.

Other University of Pennsylvania trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03982563.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing